We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+10.2%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$1.08T
AUM Growth
+$79.9B
Cap. Flow
-$8.94B
Cap. Flow %
-0.83%
Top 10 Hldgs %
25.7%
Holding
3,000
New
159
Increased
1,164
Reduced
1,499
Closed
84

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.45B
2
PINS icon
Pinterest
PINS
+$1.89B
3
TMUS icon
T-Mobile US
TMUS
+$1.89B
4
ZM icon
Zoom
ZM
+$1.77B
5
PATH icon
UiPath
PATH
+$1.71B

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$3.66B
2
CAT icon
Caterpillar
CAT
+$1.32B
3
NFLX icon
Netflix
NFLX
+$1.18B
4
MXIM
Maxim Integrated Products
MXIM
+$1.15B
5
MU icon
Micron Technology
MU
+$1.07B

Sector Composition

Rank Sector Weight
1 Technology 24.62%
2 Healthcare 16.07%
3 Consumer Discretionary 15.29%
4 Communication Services 13.46%
5 Financials 12.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IAG icon
2926
IAMGOLD
IAG
$10.2B
-375,386
Closed -$1.12M
IMUX icon
2927
Immunic
IMUX
$220M
-26,238
Closed -$4.18M
IRON icon
2928
Disc Medicine
IRON
$3.08B
-25,000
Closed -$9.65M
IYR icon
2929
CALL
iShares US Real Estate ETF
IYR
$4.56B
-2,580,600
Closed -$237M
LEGN icon
2930
Legend Biotech
LEGN
$3.99B
-124,229
Closed -$3.6M
MASS icon
2931
908 Devices
MASS
$418M
-465,287
Closed -$22.6M
MIST icon
2932
Milestone Pharmaceuticals
MIST
$136M
-267,997
Closed -$1.55M
NGD
2933
DELISTED
New Gold Inc
NGD
-509,608
Closed -$787K
NWPX icon
2934
NWPX Infrastructure Inc
NWPX
$1.11B
-6,072
Closed -$203K
NXTC icon
2935
NextCure
NXTC
$37M
-1,033
Closed -$124K
OLO
2936
DELISTED
Olo Inc
OLO
-1,300,000
Closed -$34.3M
PDFS icon
2937
PDF Solutions
PDFS
$2.16B
-2,007,056
Closed -$35.7M
PMVP icon
2938
PMV Pharmaceuticals
PMVP
$68.8M
-119,375
Closed -$3.93M
QQQ icon
2939
CALL
Invesco QQQ Trust
QQQ
$485B
-781,900
Closed -$250M
QQQ icon
2940
PUT
Invesco QQQ Trust
QQQ
$485B
-3,900
Closed -$1.25M
STRO icon
2941
Sutro Biopharma
STRO
$358M
-2,140
Closed -$487K
TARA icon
2942
Protara Therapeutics
TARA
$229M
-319,326
Closed -$5.03M
UFI icon
2943
UNIFI
UFI
$126M
-9,035
Closed -$249K
AD
2944
Array Digital Infrastructure
AD
$3.08B
-12,515
Closed -$457K
XLF icon
2945
State Street Financial Select Sector SPDR ETF
XLF
$59.3B
-20,625
Closed -$754K
RPT
2946
Rithm Property Trust
RPT
$101M
-20,978
Closed -$1.37M
ENLC
2947
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
-23,923
Closed -$103K
VIRX
2948
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
-510,000
Closed -$4.72M
MRNS
2949
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
-42,186
Closed -$653K
SFE
2950
DELISTED
Safeguard Scientifics, Inc.
SFE
-657,658
Closed -$4.49M

Similar funds

T. Rowe Price Associates's Q2 2021 Portfolio in Review

As of Q2 2021, T. Rowe Price Associates held 3,000 positions worth $1.08T, up 8% from $999B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q2 2021 filing shows 159 new, 1,164 increased, 1,499 reduced and 84 closed positions. Its largest new stake was UiPath: 23,377,090 shares worth $1.52B. The largest sale was Alibaba, an estimated $3.66B.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2021 buy was UiPath: 23,377,090 shares worth $1.52B.
  • T. Rowe Price Associates added most to Microsoft in Q2 2021, an estimated $3.45B increase.
  • T. Rowe Price Associates's biggest Q2 2021 reduction was Alibaba, cutting an estimated $3.66B.
  • T. Rowe Price Associates fully exited Pershing Square Tontine Holdings, Ltd. in Q2 2021, selling an estimated $145M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $1.08T portfolio in Q2 2021.
  • T. Rowe Price Associates opened 159 new positions and closed 84 in Q2 2021.
  • T. Rowe Price Associates's portfolio value rose 8% quarter-over-quarter to $1.08T.

Based on T. Rowe Price Associates's 13F filing for Q2 2021, filed 16 Aug 2021.